Company profile: Aprecia
1.1 - Company Overview
Company description
- Provider of precision drug delivery systems and products, including CustomRelease time-release profiles; ZipDose 3D printing for rapidly dissolving, high-dose oral tablets with taste-masking and IR/ER options; Spritam (levetiracetam); Binder Jet 3DP technology; in-cavity 3D tablet forming; capsule form & fill automation; and early-stage formulation support and rapid prototyping services.
Products and services
- Spritam (levetiracetam): FDA-approved, first 3D-printed drug engineered for oral suspension, available in multiple dose strengths and created for oral dosing via suspension
- ZipDose Technology: High-dose 3D printing platform creates rapidly dissolving oral tablets with taste-masking options and IR/ER combinations, pairing a high dose ceiling with orally dispersing behavior
- Binder Jet 3DP Technology: Heat-free powder-based pharmaceutical 3D printing process that allows a wide range of material compatibility, architected to fabricate drug products without thermal constraints.
Key contacts
🔒
🔒
Financial details
🔒
1.2 - Competitors and similar companies to Aprecia
Acea Biosciences
HQ: United States
Website
- Description: Provider of high-performance microelectronic systems for cell-based assays, developed and commercialized by a biotechnology company.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Acea Biosciences company profile →
SkinBioTherapeutics
HQ: United Kingdom
Website
- Description: Provider of probiotic bacteria lysate-based skin technologies and products, including the SkinBiotix platform to improve skin barrier integrity, repair and reduce bacterial load; AxisBiotix-Ps probiotic supplement for psoriasis; cosmetic skincare for sensitive skin and anti-aging; food supplements for eczema, psoriasis and acne; medical skin care and infection control solutions for hospital and domestic settings.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full SkinBioTherapeutics company profile →
Keyence
HQ: Japan
Website
- Description: Provider of sensors (photoelectric, fiber optic, laser, inductive proximity, vision), measurement sensors (laser profilers, displacement sensors, optical micrometers), machine vision systems, barcode readers, laser markers, process sensors (flow, pressure, temperature), safety equipment (light curtains, laser scanners, interlock switches), and digital/laser microscopes for factory automation and manufacturing.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Keyence company profile →
Sartorius
HQ: Germany
Website
- Description: Provider of laboratory and process technologies and equipment for biopharmaceutical production and laboratory environments, offering bioprocess solutions including filtration, fermentation, and purification technologies, and lab products and services with instruments and consumables for research and quality control, helping develop and manufacture biotech medicines reliably, quickly, and economically.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Sartorius company profile →
Neurescence
HQ: Canada
Website
- Description: Provider of biological optical imaging solutions for neuroscience, offering miniature fluorescence microscopes and systems for dual-color, multi-region, and cellular-resolution calcium imaging in freely behaving animals, with synchronized behavioral data and optogenetic manipulation, plus software and a cloud platform to manage, analyze, and share multimodal research data.
- Rationale: This competitor operates in a highly similar market segment with overlapping features.
- Company type: Private company
- Employees: ●●●●●
- Total funding raised: $●●●m
- Backers: ●●●●●●●●●●
- Acquisitions: ●●
View full Neurescence company profile →
🔒
2.M&A buyers
2.1 Potential strategic acquirers in the sector
🔒
🔒
🔒
🔒
View all strategic buyers with complete profiles
Start Free Trial →
2.2 - Strategic buyer groups for Aprecia
🔒
Buyer group 1: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 2: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔒
Buyer group 3: ████████ ████████
●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒
View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →
3. Investors and private equity firms
3.1 - Buyout funds investing in similar companies to Aprecia
2.2 - Growth funds investing in similar companies to Aprecia
🔒
View all growth equity funds with complete profiles
Start Free Trial →
4 - Top valuation comps for Aprecia
4.2 - Public trading comparable groups for Aprecia
🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →